The latest announcement is out from BioCardia ( (BCDA) ).
On March 31, 2025, BioCardia, Inc. announced a clarification regarding the timing of its conference call to discuss the two-year CardiAMP-HF results. Initially reported to occur at 4:30pm PDT, the call was confirmed to take place at 4:30pm EDT. This announcement ensures stakeholders are informed of the correct timing to access the call, which is crucial for maintaining transparency and effective communication regarding the company’s clinical progress.
More about BioCardia
BioCardia, Inc. is a global leader in cellular and cell-derived therapeutics, focusing on the treatment of cardiovascular and pulmonary diseases.
YTD Price Performance: 23.89%
Average Trading Volume: 49,634
Technical Sentiment Signal: Buy
Current Market Cap: $13.1M
Learn more about BCDA stock on TipRanks’ Stock Analysis page.